TD Cowen Maintains Buy on BrightSpring Health, Raises Price Target to $81

Benzinga Newsdesk www.benzinga.com Positive 75.5%

Neg 0% Neu 0% Pos 75.5%

TD Cowen analyst Charles Rhyee maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $65 to $81.